Suit alleges Purdue's OxyContin turned eastern Kentucky into "Wild West"; AbbVie-Shire $1.6B break-up fee could be tax write-off; Lilly CEO tells WSJ that 2014 has been "toughest year."
In an estimated $30-million deal, Pennsylvania healthcare comms agency Cadient Group is to be acquired by tech consultancy Cognizant.
Cadient is being acquired by consultancy Cognizant; Valeant ups the ante in Allergan bid; BMS settles Sustiva patent suits; Americans are dying at a lesser rate; Stricter Ebola screening at aiprorts.
The acquisition is meant to bolster the WPP agency's payer and market-access capabilities.
The pharmaceutical industry's need for promotional spending has never been greater
The results are in! Here are the Gold and Silver Award winners from the 2014 MM&M Awards:
The great thing about TEDMED—the promise of the brand—is that it will inspire you to see the world differently. On this most important score, TEDMED succeeded in some spectacular ways.
Brown has stepped down as general manager of the IPG network to lead the GuideMark Health agencies as CEO.
A US Pharma juror's—and silver Lions Health winner's—opinion on why the Americans didn't fare well in Cannes, and tips for improvement
The Omnicom-Publicis deal may have been scuttled, but the hunger for deals remains.
Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.